ORMD-0801

· Oramed Pharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for ORMD-0801, covering 2014-10-24 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. [Phase 3]

See pricing